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Background Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) is associated with poor outcomes. Improvement in 
pharmacology/technologies might translate in better outcomes after SVG PCI. However, there is limited data informing if the current practice has 
translated in better outcomes after SVG PCI.
Methods We identified 3717 patients (pts) undergoing SVG PCI from 1990-2008. The population was divided in 2 groups: pts performed between 
1990-1999, n=1948 (group 1); and 2000-2008, n=1769 (group 2). Clinical outcomes were collected at 1-year follow-up.
Results Pts in group 2 presented more frequently with acute MI and have higher rate of comorbidities than pts in group 1 (Table). Additionally pts in 
group 2 presented more and complex coronary disease, although more lesions were dilated in pts in group 1. Clinical success was achieved in 97.5% 
and 94.3% of pts in group 2 and 1, respectively (p<0.001). Despite the more complex population/presentation the group 2 has less peri-procedural 
MI (13.7% vs 17.5%, p=0.002) and developed less major bleeding complication (1.8% vs 5.7%, p<0.001). At 1-year follow-up the mortality rate remain 
similar between the 2 groups, however the rate of Q-wave MI and TLR was significantly lower in pts performed in the last decade (Table).
Conclusions Despite a significant improvement observed in peri-procedural and long-term outcomes after SVG PCI in the last decade, this 
improvement was not translated to modify the high mortality rate in this complex population. 
Table. Clinical & Angiographic Characteristics & Long-term Outcomes
Group 1
[1990-1999 period]
(n= 1,948)
Group 2
[2000-2008 period]
(n = 1,769)
P value
Clinical characteristics, n (%)
Age 67.1 ± 9.6 68.8 ± 12.5 <0.001
Male gender 1507 (77.6) 1302 (73.7) 0.007
Diabetes 674 (34.9) 821 (46.9) <0.001
Peripheral vascular disease 370 (26.5) 512 (29.6) 0.06
Chronic renal failure 174 (12.4) 353 (20.3) <0.001
Prior MI 1159 (61.6) 714 (45.9) <0.001
History of PCI 685 (35.6) 674 (44.9) <0.001
Heart failure 311 (22.4) 404 (24.0) 0.27
Clinical presentation, n (%)
Acute MI 28 (1.5) 182 (10.4) <0.001
Unstable angina 1490 (77.9) 963 (54.8) <0.001
Stable angina 394 (20.6) 613 (34.9) <0.001
Cardiogenic shock 32 (1.9) 51 (2.7) 0.41
Angiographic characteristics n= 3623 n= 2946
Number of vessel diseased, mean ± SD 2.6 ± 0.7 2.7 ± 0.6 0.06
Number of lesion dilated, mean ± SD 1.9 ± 1.1 1.6 ± 1.0 <0.001
ACC/AHA type C lesion, n (%) 869 (35.7) 1105 (39.5) 0.004
Outcomes at 1-year follow-up, n (%) n= 1040 n= 1757
Death 195 (11.1) 103 (9.9) 0.32
Q-wave MI 17 (1.1) 2 (0.2) 0.012
Target lesion revascularization 333 (20.4) 70 (7.0) <0.001
